Viking Therapeutics, Inc. (VKTX)
30.49
+1.94
(+6.80%)
USD |
NASDAQ |
Feb 12, 16:00
30.65
+0.16
(+0.52%)
After-Hours: 04:33
Viking Therapeutics Free Cash Flow : -278.68M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 6.436B |
| Pfizer Inc. | 10.38B |
| Amgen, Inc. | 9.958B |
| Biogen, Inc. | 1.969B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -85.29M |
| Cash from Investing (Quarterly) | 75.61M |
| Cash from Financing (Quarterly) | 75.10M |
| Free Cash Flow Per Share (Quarterly) | -0.7481 |
| Free Cash Flow to Equity (Quarterly) | -84.67M |
| Free Cash Flow to Firm (Quarterly) | -85.29M |
| Free Cash Flow Yield | -8.12% |